| famuyiyaoi | Дата: Пятница, 21.03.2014, 06:11 | Сообщение # 1 |
|
Группа: Бандит
| Tacrolimus (also FK-506 or fujimycin, truck names Prograf, Advagraf, Protopic) is an immunosuppressive opiate that is most of all in use accustomed to after allogeneic organ move to reduce the vocation of the passive's immune system and so lower the danger of process rejection. It is also used in a up to date preparation in the treatment of atopic dermatitis (eczema), strict refractory uveitis after bone marrow transplants, exacerbations of minimal change blight, and the skin condition vitiligo.
It is a 23-membered macrolide lactone discovered in 1984 from the fermentation broth of a Japanese filth representative that contained the bacteria Streptomyces tsukubaensis. It reduces interleukin-2 (IL-2) making during T-cells.
Yesteryear
Tacrolimus was discovered in 1984; it was middle the opening macrolide immunosuppressants discovered, preceded at near the invention of rapamycin (sirolimus) on Rapa Nui (Easter Atoll) in 1975.<> - It is produced by a breed of loam bacterium,Streptomyces tsukubaensis.<> - The high regard tacrolimus is derived from 'Tsukuba macrolide immunosuppressant'.<> -
Tacrolimus was first approved by means of the Commons and Cure-all Management (FDA) in 1994 someone is concerned make use of in liver transplantation; this has been extended to include kidney, resolution, small bowel, pancreas, lung, trachea, husk, cornea, bone marrow, and limb transplants.
Availability
The branded variation of the drug is owned sooner than Astellas Pharma, and is sold secondary to the trade names Prograf assumption twice everyday,Advagraf, a unceasing releasing formulation allowing in the good old days daily dosing, and Protopic (Eczemus in Pakistan past Brookes Pharma), the current formulation.<> - Advagraf is at one's fingertips in 0.5, 1, 3 and 5 mg capsules, the ointment is concentrations of 0.1% and 0.03%.
A other once-daily formulation of tacrolimus is in Phase 3 clinical trials in the U.S. and Europe. This formulation also has a smoother pharmacokinetic vigorish that reduces the peak-to-trough rank in blood levels compared to twice-daily tacrolimus.<> - Data from the to begin Viewpoint 3 woe in stable kidney move patients showed that this once-daily formulation was non-inferior in efficacy and sanctuary compared to twice-daily tacrolimus.<> - A second Slant gradually introduce 3 litigation in de novo patients is ongoing.<> -
Monism of encounter
Tacrolimus is chemically known as a macrolide. In T-cells, activation of the T-cell receptor normally increases intracellular calcium, which acts via calmodulin to get started calcineurin. Calcineurin then dephosphorylates the transcription go-between NF-AT (nuclear part of activated T-cells), which moves to the pith of the T-cell and increases the undertaking of genes coding to save IL-2 and related cytokines. Tacrolimus prevents the dephosphorylation of NF-AT.<> - In detail, Tacrolimus reduces peptidyl-prolyl isomerase operation at hand binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex. This FKBP12-FK506 complex interacts with and inhibits calcineurin therefore inhibiting both T-lymphocytesignal transduction and IL-2 transcription.<> - Although this action is nearly the same to ciclosporin, studies secure shown that the degree of shrewd rejection is reduced by tacrolimus exigency execrate from ciclosporin.<>0 - Although short-term immunosuppression with an eye to acquiescent and scion survival is institute to be comparable between the two drugs, tacrolimus results in a more favorable lipid good, and this may have urgent long-term implications given the prognostic act upon of rejection on graft survival.<>1 -
|
| |
|
|
